ONCAlert | 2017 NANETS Symposium

Latest NewsMORE >>

According to results reported at the 2017 international meeting of the European Society of Gynaecological Oncology (ESGO 20), maintenance therapy with olaparib monotherapy was safe and provided clinically significant, long-term treatment benefits in patients with platinum-sensitive relapsed serous ovarian cancer.

Latest JournalAll Journals >>

Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.